News Sentiment

ATX sentiment intelligence

Amplia Therapeutics Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 20 relevant articles
Exchange ASX Australia
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.15 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

90/100 classification confidence.

Company focus 20

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-3.3% over one week, +31.8% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Amplia Therapeutics Issues New Employee Incentive Options

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 90/100 classification
One-week reaction -3.3% Price reacting lower
Trend fit Trend inactive 31.8% over four weeks
Fair value 30.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 18
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 20
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Intellia Therapeutics 5
Kalkine 4
Stockhead 2
intelligentinvestor.com.au 2
TipRanks 1
Market source 1
simplywall.st 1
SMH.com.au 1

Event Lens

What the news is about

Classified themes
Market update 17
Earnings 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-20 of 20